University of Chicago
Chicago, Illinois, 60637, United States
NCT Number: NCT04112953
The purpose of this study is to better understand if transesophageal echocardiography during cardiac surgery can predict problems with kidney function after cardiac surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Chicago, Illinois, 60637, United States
Informed consent will be obtained prior to surgery. Preoperative demographic and baseline clinical data will be collected. We will assess the patient's risk of postoperative AKI using the validated Cleveland clinic score based on preoperative risk factors and calculate the European System Operative Score Risk Evaluation score (EuroSCORE II). After standard anesthesia induction and intubation, a TEE probe will be inserted by a cardiac anesthesiologist, who is certified in intraoperative echocardiography. We will use a standard ultrasound machine (EPIQ 7 Philips;Philips, Bothell, WA). Images of the right or left kidney along with Doppler flow and velocities will be obtained prior to cardiopulmonary bypass (CPB), after CPB, and after chest closure. Images of the portal vein with Doppler flow and velocity will be obtained prior to CPB, after CPB, and after chest closure. Vitals signs and hemodynamic data will be collected concurrently during these times. (See Data Sheet) Concurrent ECG will be obtained to identify the phases of the cardiac cycle. Mean arterial pressure (MAP) will be maintained within 20% of baseline MAP with bolus or continuous infusion of vasopressors (phenylephrine, norepinephrine, epinephrine, vasopressin, ephedrine). Cardiopulmonary bypass management will be standard, with target systemic blood flow of 2.4L/min/m2. Postoperative data will include urine output, serum creatinine, calculated GFR (using Modification of Diet in Renal Disease [MDRD] method) hospital and ICU length of stay, and 30-day mortality.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: intra-operative measurement
Pulsed-wave Doppler measurement of portal vein flow and portal hypertension
Time frame: intra-operative measurement
A sonographic index to assess for renal arterial disease measured via pulsed-wave Doppler
Time frame: 30 days post-operation
Length of ICU stay at any point for 30 days post-operation will be recorded
Time frame: 30 days post-operation
Length of Hospital stay up to 30 days post-operation will be recorded
Time frame: 30 day post-operation
Standard measure post
University of Chicago
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07510672
AKI, Arrhythmias, Cardiac
Padova, PD, Italy
View Trial DetailsNCT05036616
AKI
Bangkok, Thailand
View Trial DetailsNCT04351906
AKI, ARDS
Giessen, Hesse, Germany
View Trial DetailsNCT04008810
AKI, Acute Kidney Injury
Hillerød, Denmark
View Trial Details